West Pharmaceutical Services Return On Tangible Equity 2010-2024 | WST

West Pharmaceutical Services return on tangible equity for the quarter ending September 30, 2024 was 19.18.

  • West Pharmaceutical Services average return on tangible equity for 2023 was 21.5, a 26.52% decline from 2022.
  • West Pharmaceutical Services average return on tangible equity for 2022 was 29.26, a 5.03% decline from 2021.
  • West Pharmaceutical Services average return on tangible equity for 2021 was 30.81, a 47.98% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

West Pharmaceutical Services Return On Tangible Equity 2010-2024 | WST

  • West Pharmaceutical Services average return on tangible equity for 2023 was 21.5, a 26.52% decline from 2022.
  • West Pharmaceutical Services average return on tangible equity for 2022 was 29.26, a 5.03% decline from 2021.
  • West Pharmaceutical Services average return on tangible equity for 2021 was 30.81, a 47.98% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.